Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Arcutis Biotherapeutics (ARQT) Leases: 2020-2025

Historic Leases for Arcutis Biotherapeutics (ARQT) over the last 6 years, with Sep 2025 value amounting to $4.6 million.

  • Arcutis Biotherapeutics' Leases rose 121.70% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 121.70%. This contributed to the annual value of $2.0 million for FY2024, which is 17.28% down from last year.
  • Per Arcutis Biotherapeutics' latest filing, its Leases stood at $4.6 million for Q3 2025, which was up 164.29% from $1.7 million recorded in Q2 2025.
  • Over the past 5 years, Arcutis Biotherapeutics' Leases peaked at $4.6 million during Q3 2025, and registered a low of $1.7 million during Q2 2025.
  • Over the past 3 years, Arcutis Biotherapeutics' median Leases value was $2.3 million (recorded in 2024), while the average stood at $2.4 million.
  • Per our database at Business Quant, Arcutis Biotherapeutics' Leases spiked by 1,346.46% in 2021 and then dropped by 20.11% in 2025.
  • Arcutis Biotherapeutics' Leases (Quarterly) stood at $3.0 million in 2021, then declined by 10.49% to $2.7 million in 2022, then decreased by 13.23% to $2.4 million in 2023, then fell by 17.28% to $2.0 million in 2024, then skyrocketed by 121.70% to $4.6 million in 2025.
  • Its last three reported values are $4.6 million in Q3 2025, $1.7 million for Q2 2025, and $1.8 million during Q1 2025.